NFKB1 and autoimmune disease: This second pathway plays a critical role in regulating immune homeostasis, and its dysregulation contributes to inflammatory and autoimmune diseases (77, 105–107) suggesting that RelB may act as a repressor of NF-κB-responsive gene expression.